EBQ talk:Sgarbossa Criteria Study

Revision as of 17:49, 12 April 2014 by Ostermayer (talk | contribs) (Ostermayer moved page EBQ talk:Sgarbossa Criteria to EBQ talk:Sgarbossa Criteria Study)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

solid work mohsen, if certain sections such as secondary outcomes don't make sense for the article you can eliminate those sections. Here is some reading that may be useful for the further discussion and criticism section

Con: http://www.ncbi.nlm.nih.gov/pubmed/21296327 http://www.ncbi.nlm.nih.gov/pubmed/18165668 http://www.ncbi.nlm.nih.gov/pubmed/19857407


Pro: http://www.ncbi.nlm.nih.gov/pubmed/24016487

the main argument is although sgarbossa is very specific it lacks sensitivity and therefore will lead to many false positive activations of cardiology